74 related articles for article (PubMed ID: 9179087)
1. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function.
Marcotte F; Honos GN; Walling AD; Beauvais D; Blais MJ; Daoust C; Lisbona A; McCans JL
Can J Cardiol; 1997 May; 13(5):479-85. PubMed ID: 9179087
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors in pediatric patients with mitral valve regurgitation-case-control study and review of the literature.
Knirsch W; Tlach L; Stambach D; Bauersfeld U
Congenit Heart Dis; 2010; 5(3):278-84. PubMed ID: 20576047
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
Schön HR
J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
[TBL] [Abstract][Full Text] [Related]
4. Mildly symptomatic chronic mitral regurgitation. Analysis of left ventricular systolic function and mitral regurgitation fraction under pharmacological influence. Echocardiographic study.
Rivera IR; Moisés VA; Carvalho AC; de Paola AA
Arq Bras Cardiol; 2003 Feb; 80(2):144-9, 138-43. PubMed ID: 12640508
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide levels in rheumatic mitral regurgitation and response to angiotensin-converting enzyme inhibitors.
Kula S; Tunaoglu FS; Olgunturk R; Gokcora N
Can J Cardiol; 2003 Mar; 19(4):405-8. PubMed ID: 12704487
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation.
Nemoto S; Hamawaki M; De Freitas G; Carabello BA
J Am Coll Cardiol; 2002 Jul; 40(1):149-54. PubMed ID: 12103269
[TBL] [Abstract][Full Text] [Related]
7. Quinapril therapy in patients with chronic mitral regurgitation.
Schön HR; Schröter G; Barthel P; Schömig A
J Heart Valve Dis; 1994 May; 3(3):303-12. PubMed ID: 8087269
[TBL] [Abstract][Full Text] [Related]
8. Effective regurgitant orifice area of rheumatic mitral insufficiency: response to angiotensin converting enzyme inhibitor treatment.
Tunaoğlu FS; Olguntürk R; Kula S; Oğuz D
Anadolu Kardiyol Derg; 2004 Mar; 4(1):3-7. PubMed ID: 15033608
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of nicorandil versus enalapril in chronic rheumatic severe mitral regurgitation: six months follow up echocardiographic study.
Gupta DK; Kapoor A; Garg N; Tewari S; Sinha N
J Heart Valve Dis; 2001 Mar; 10(2):158-65. PubMed ID: 11297201
[TBL] [Abstract][Full Text] [Related]
10. Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse.
Tischler MD; Rowan M; LeWinter MM
Am J Cardiol; 1998 Jul; 82(2):242-5. PubMed ID: 9678300
[TBL] [Abstract][Full Text] [Related]
11. Impact of chronic lisinopril therapy on left atrial volume versus dimension in chronic organic mitral regurgitation.
Wong GC; Marcotte F; Rudski LG
Can J Cardiol; 2006 Feb; 22(2):125-9. PubMed ID: 16485047
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity.
Harris KM; Aeppli DM; Carey CF
Am Heart J; 2005 Nov; 150(5):1106. PubMed ID: 16291006
[TBL] [Abstract][Full Text] [Related]
13. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation.
Wisenbaugh T; Sinovich V; Dullabh A; Sareli P
J Heart Valve Dis; 1994 Mar; 3(2):197-204. PubMed ID: 8012639
[TBL] [Abstract][Full Text] [Related]
14. [Long-term treatment with quinapril in chronic aortic and mitral insufficiency].
Schön HR; Schömig A
Dtsch Med Wochenschr; 1995 Mar; 120(13):429-35. PubMed ID: 7712932
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function.
Ray JG
Can J Cardiol; 1997 Aug; 13(8):780-1, 783. PubMed ID: 9284846
[No Abstract] [Full Text] [Related]
16. Tricuspid regurgitation in patients with severe mitral regurgitation and normal left ventricular ejection fraction: risk factors and prognostic implications in a cohort of 895 patients.
Varadarajan P; Pai RG
J Heart Valve Dis; 2010 Jul; 19(4):412-9. PubMed ID: 20845886
[TBL] [Abstract][Full Text] [Related]
17. Mitral regurgitation in patients with coronary artery disease and low left ventricular ejection fractions. How should it be treated?
Christenson JT; Simonet F; Maurice J; Bloch A; Velebit V; Schmuziger M
Tex Heart Inst J; 1995; 22(3):243-9. PubMed ID: 7580362
[TBL] [Abstract][Full Text] [Related]
18. Acute severe mitral regurgitation during first attacks of rheumatic fever: clinical spectrum, mechanisms and prognostic factors.
Kamblock J; N'Guyen L; Pagis B; Costes P; Le Goanvic C; Lionet P; Maheu B; Papouin G
J Heart Valve Dis; 2005 Jul; 14(4):440-6. PubMed ID: 16116868
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of valvular lesion and left ventricular size in asymptomatic patients with chronic organic mitral regurgitation and normal left ventricular performance.
Krauss J; Pizarro R; Oberti PF; Falconi M; Cagide A
Am Heart J; 2006 Nov; 152(5):1004.e1-8. PubMed ID: 17070180
[TBL] [Abstract][Full Text] [Related]
20. Quantification of left ventricular interstitial fibrosis in asymptomatic chronic primary degenerative mitral regurgitation.
Edwards NC; Moody WE; Yuan M; Weale P; Neal D; Townend JN; Steeds RP
Circ Cardiovasc Imaging; 2014 Nov; 7(6):946-53. PubMed ID: 25140067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
